Lifeline Reproductive Medical Center

Hospital name: Lifeline Reproductive Medical Center

External abbreviation: Lifeline Reproductive Medical Center

Type: Assisted reproductive hospital

Talent configuration:> 100

Country: Russia

Region: Moscow

Support technologies: third-generation IVF, embryo freezing, IVF/ICSI, third-party assisted reproductive services

Cost estimate: 530,000 - 650,000 yuan

Hospital Location: Moscow, Russia

Reason for recommendation: Russia has a very good success rate

Lifeline Reproductive Medical Center is a leader among Russian reproductive specialized hospitals. It is a high-level and high-standard medical institution. It is a hospital with designated medical insurance qualifications of The Russian Federation. It is located in

The capital of Russia, Moscow, was established in 2008 and has two branches in Moscow.

The hospital has world-advanced equipment and hygiene

The Supreme Court of Standards now has a team of doctors who are well-known in the Russian assisted reproduction community. Many attending doctors have more than 20 years of experience and excellent reputation.

Lifeline Expert Team Lifeline Reproductive Medical Center currently has two branches, with nearly 100 staff members, including 35 doctors and 15 embryologists. Most of the doctors and annulologists hold doctoral degrees

Average experience of more than 10 years.

Doctor of Obstetrics and Gynecology, Director of Lifeline Assisted Reproduction Department, Chief Physician of Obstetrics and Gynecology Department, and Expert on Reproductive Rights in Russia. Expert who specializes in using reproductive methods to treat infertility, has had 14 years of infertility

Treatment work experience. Russian Society for Human Reproduction, member of the European Society for Human Reproduction.

Russian expert in the field of assisted reproduction and deputy director of the Reproductive Department of Lifeline Assisted Reproduction Center. Graduated from Sedonov State Medical University in Moscow, Russia in 1988. Received a medical doctor's degree in 1994

He also serves as a professor at Xie Yi's two schools of Obstetrics and Gynecology and Elective Communication. Specialize in using small doses to promote excretion and obtain more sperm counts. Member of the Russian Reproductive Society, member of the European Human Reproductive Society, former

Served as director of the reproductive department at the European Medical Center (EMC) in Russia for the first time. Member of the treatment team for the first CS treatment in Russia.

Reproductive specialist, Doctor of Obstetrics and Gynecology, Medical academician, Chief Physician of Lifeline Obstetrics and Gynecology. Associate Professor at the Graduate School of the Russian National Academy of Medicine, and once served as a guest of reproductive medicine at the School of Medicine of Tongji University, Shanghai

Professor 2 years and 13 years of experience in infertility treatment have conducted academic exchanges and lectures in Russia and many countries around the world. Honorary editor-in-chief of Russia's "Assisted Reproduction Problems and Solutions", Russian

Reproductive Society, member of the European Society for Human Reproduction.

Lifeline Pu Reproductive Assisted Medical Center Chief Physician, MD. He is currently a visiting professor at the Moscow State Academy of Obstetrics and Gynecology, and a senior researcher at the Department of Ultrasound Diagnosis, Moscow Medical Institute, Russia

Researcher.

Graduated from the Russian State Research Medical University of Pirogov in 1998, and worked in the Department of Obstetrics and Genetics of Obstetrics and Genetics of the People's Friendship Hospital of Russia from 1998 to 2005. In infertility not

In the field of reproductive therapy, he has published more than 20 academic papers and published them in the authoritative local journal of Oros. He has won the Reproductive Endocrinology Mining Paper Award of the Russian Society of Reproductive Medicine. Invited by the hungry federal government many times to participate in

Research on population and reproductive medicine. I have been invited many times by Russian state television, radio, and medical and health care departments. As a senior doctor, I participated in ancient times and handled successfully born test-tube babies.

and more than a thousand cases.

Graduated from Moscow State Medical University in 2006 with a bachelor's degree in pediatrics and privacy. In 2010, he graduated from Sedonov Medical College in Moscow, Russia. His graduation thesis is "Ultrasound Technology in Gynecology

and Research and Applications in Genetics "has won many awards in Europe. Published more than 10 papers in authoritative Russian magazines and holds the qualification of an ultrasound diagnostic expert issued by the Russian Federation of Health Affairs

Master all methods for treating pregnancy and fertility, operate and successfully operate many donation projects and fertility assistance projects for international customers, member of the Russian Human Reproduction Office, member of the European Association of Human Reproduction.

Hospital Name: Altravita Hospital

Short term: Altra-Vita

Level: To be updated

Type: Assisted reproductive hospital

Talent configuration:> 100

Country: Russia

Region: Moscow

Supporting technologies: third-generation IVF, embryo freezing, IVF/ICSI, third-party assisted reproductive services

Cost estimate: 510,000 - 630,000 yuan

Hospital Location: 4A,Nagornaya st., Moscow,Russia

Reason for recommendation: Russia's relatively cheap hospitals

The design and equipment configuration of hospital facilities adopt the standards of the American Society for Reproductive Medicine (ASRM), and listen to the advice of senior directors of similar hospitals in the United States. Altravita Hospital only complies with the United States and Western European countries

The advantages of the Altravita Reproductive Medicine Center--high-level embryos

Laboratory, the laboratory is equipped with the latest equipment from internationally renowned companies.

The laboratory uses high-quality medical consumables from around the world and provides a suitable embryo culture environment. Some of the equipment is original to the hospital and has been patented in the United States. Altravita Reproductive Medicine Center

The management of the embryo laboratory adopts a strict American quality management system certified by the American College of Pathologists.

Altravita is a well-known assisted reproductive medical institution in Russia: it has more than 50 assisted reproductive doctors and related expert teams, and completed more than 4000 cycles of assistance in 2017 alone.

Reproductive medical projects have far more experience and customers than overseas counterparts.

Under the leadership of founder Sergey Jakovenko and the joint efforts of many senior medical experts, since its establishment in 2002, the success rate of Altravita IVF has been higher than that of Europe. The average is nearly 15

%, which is nearly 10% higher than the U.S. average.

Altravita's success is inseparable from the doctor's plan and experience, but also due to the cultivation and cultivation in the embryo laboratory. Altravita's high-standard laboratory, with medical standards certified by the U.S. FDA and high-quality

The process and facilities are designed to meet the American Society of Reproductive Medicine (ASRM) standards, and the embryo laboratory is recognized by the American College of Pathologists (AP) Gold Quality Standard.

Professor "Cell Technology" and "Biophysical Methods of Assisted Reproductive Technology" has published more than 240 academic papers in the past 20 years, and has mastered dozens of patented technologies. Name of President Vladimir Putin, the leader in the field of assisted reproductive technology in Russia

Honored Scientific Advisor ASRM Member (American Society of Reproductive Medicine), APART Association for Private Clinics and Laboratory Assisted Reproductive Technology)ESHTE National * Table (European Society of Human Reproduction and Embryology) Selected into World Medical System

Chairman of the Medical Tourism Industry Alliance, Member of the Regular Meeting between the Chinese and Russian Prime Ministers, Member of the Economic and Trade Cooperation Sub-Committee, Advisor to the Russian Ministry of Economic Development and Trade, The Russian Federation Advisor to the Ministry of Education and Science, Lead a Road to China and Russia

Deepening Strategic Partnership Strategic Participants

It mainly studies the diagnosis and treatment of the causes of female infertility and marital infertility, including the use of assisted reproductive technology. Use of reproductive surgery and endoscopies (hysteroscopy and laparoscopy) in gynecology

Study on patency of fallopian tubes.

Hospital name: Russian MD Medical Group

External abbreviation: MD Medical Group

Level: To be updated

Type: Assisted reproductive hospital

Talent configuration:> 200

Country: Russia

Region: Saint Petersburg, Russia

Recommended doctor: Andrea

Supporting technologies: in vitro fertilization/pre-pregnancy prenatal diagnosis, etc.

Cost estimate: 550,000 - 700,000

Hospital Location: No. 88 Middle Street, St. Petersburg

Reason for recommendation: Special maternity services can be provided

Russia's MD Medical Group ranks among the best in terms of the number of IVF cycles and is also the first among family private medical services. It is currently the largest maternal and infant institution in Russia. Its service scope

Covering all fields of obstetrics, gynecology and pediatrics, the hospital has an elegant environment, advanced equipment, and strictly implements EU standards. In 2018, there were a total of 16,636 IVF cases.

Mr. Marko Arkadi, founder and chairman of the board of directors of the group, is a doctor of medicine and a member of the Russian Academy of Medical Sciences. Currently, 5 hospitals and 35 hospitals have been opened in 25 cities in Russia and Ukraine

The clinic has more than 7000 qualified experts, of which about 2000 registered doctors have rich knowledge and advanced qualifications. Since October 12, 2012, the company's shares have been issued in Global Depositary Receipts (G

DR) is listed on the London Stock Exchange (LSE Ticker "MDMG"), and it is the exclusive Russian medical company to successfully complete an IPO in London.

MD Group has won many awards in the direction of maternal and infant. Over the years, it has accumulated a very good reputation in Russia and has become a maternal and infant hospital for the elite of Russian society. Maternal and child health is one of the things that the Russian government attaches great importance to

In all directions, President Putin is very concerned about the development of MD Group. He has inspected MD Group's hospitals in various places many times and gave very high comments, affirming the MD Group's concern for maternal and infant health in Russia

Contribution to the cause.

Currently, MD Group has opened 5 hospitals and 35 clinics in 25 cities in Russia and Ukraine, and has more than 7000 qualified experts, of which about 2000 registered doctors have rich knowledge

and advanced qualifications.

Hospital Name: Avapet Hospital AVA-peter

External abbreviation: Avapet Hospital

Level: ISO-9001 Certification

Type: Private hospital

Talent configuration:> 200

Country: Russia

Region: Petrograd District, Saint Petersburg, Russia

Supporting technologies: Assisted reproductive technology, artificial insemination, IVF, etc.

Cost estimate: 560,000 - 700,000

Hospital location: St Petersburg petrogradsky District of Russia

Reason for recommendation: Wapet Hospital is an official member of the Russian Human Reproduction Association and officially passed ISO-9001 certification in 2010.

AvA-peter Hospital (AVA-peter) located in St. Petersburg, Russia is currently popular among intermediary service agencies. AvA-peter Hospital is located in

Officially established in 1996, the hospital is located in St. Petersburg, Russia.

Avapet Hospital, which focuses on treating infertile patients through reproductive technology, has completed thousands of test-tube babies since its establishment, helping many infertile families have a baby.

Dream, Mom Dream.

After decades of development, Avapit Hospital has made breakthrough development in the latest field of assisted reproductive technology. It has successively established Vologda Hospital Branch Hospital, Kazan Branch Hospital, becoming

became an official member of the Russian Human Reproduction Association and officially approved the ISO-9001 certification in 2010.

Hospital Name: Alte Hospital

External abbreviation: Alte Hospital

Level data: To be updated

Type: Private hospital

Talent configuration:> 100

tCountry: Russia

Region: Southern Administrative District of Moscow, Russia

Support technologies: Assisted reproduction, IVF technology, etc.

Cost estimate: 500,000 - 620,000 yuan

Hospital location: Moscow,Russia

Reason for recommendation: The hospital has given birth to more than 7000 healthy babies through IVF technology, helping a large number of infertile couples realize their family wishes.

Like Altra Vita Hospital, the Alte Hospital described below is also a long-established IVF specialist hospital from Russia. Its Dean Card

Lenina is an expert in operating the first test-tube baby born in the Soviet Union in 1986 and the director of the hospital.

Currently, there are more than 30 experts and professors in various departments in Alte Hospital, all of whom are doctors with a lot of clinical practice experience, and have also won various awards awarded by the state many times. Since its establishment

The hospital has completed more than 7000 healthy babies through IVF technology, helping a large number of infertile couples realize their family wishes.

Alte Hospital has strictly implemented EU standards and Russian national standards since its establishment. It is able to provide very comprehensive diagnosis and treatment of infertile couples. It also has various advanced technologies and medical treatment

Therapy equipment implements PGD testing on embryos from elderly families by implementing the third-generation IVF technology to exclude embryos carrying disease-causing genes.